Vertex Pharmaceuticals is getting bullish attention from analysts, especially Cantor Fitzgerald, which predicts earnings of ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 13 Biotech Stocks with Huge Upside Potential. The company ...

According to a Worker Adjustment Retraining Notification written by Vertex to the R.I. Department of Labor and Training, ...

Vertex said in its WARN letter that the jobs will start ending on Aug. 5, and will consolidate the Providence campus.

Delivered as a once-daily 30 mg/mL IV bolus injection over 15 seconds, Xifyrm can be used alone or alongside non-NSAID ...

The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce ...

Vertex Pharmaceuticals is laying off workers and consolidating its real estate footprint in Rhode Island after ending a ...

The layoffs will be effective on Aug. 5, according to a letter sent to the state’s Department of Labor and Training.

Vertex is trimming its Rhode Island footprint on the back of a scrapped “cells plus device” program in diabetes, leaving 125 ...

Shares of CRISPR Therapeutics CRSP have risen 14% over the past month, likely driven by encouraging results from the first candidates in its in vivo pipeline. CRSP’s Positive In Vivo Therapy Data Last ...